Frontiers in Immunology · 2017 · 30 citations · 36 references
Life SciencesImmunologyInfectious DiseasesCellular ImmunologyClinical ImmunologyImmunology Of Infectious DiseasesCell-mediated ImmunityCellular Immunity In InfectionCytotoxic T Lymphocyte ResponsesEffector T Cell FunctionT Cell ActivationT Cell BiologyCd8 Positive T CellsFlow Cytometric Cell AnalysisProgrammed Cell Death PathwaysProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Cell Death RegulationT Cell ImmunologyT-cell ImmunophenotypesViral Replication Control
Background: CXCR5+CD8+T cells have been demonstrated to play an important role in the control of chronic viral replication; however, the relationship between CXCR5+CD8+T cells, HIV disease progression, and PD-1 expression profile on CXCR5+CD8+T cells during HIV infection remain poorly understood. Methods: We enrolled a total of 101 HIV patients, including 62 typical progressors (TPs), 26 complete responders (CRs), and 13 immune non-responders (INRs). Flow cytometric analysis, immunohistochemical staining, and relative function (i.e., cytokine secretion and PD-1 blockade) assays were performed to analyze the properties of CXCR5+CD8+T cells. Results: HIV-specific CXCR5+CD8+T cells in the peripheral blood and distribution of CXCR5+CD8+T cells in the lymph node (LN) were negatively correlated with disease progression during chronic HIV infection. PD-1 was highly expressed on CXCR5+CD8+T cells and positively associated with peripheral CD4+ T cell counts. Functionally, IFN-γ and TNF-α production of CXCR5+CD8+T cells were reduced by PD-1 pathway blockade, but the production of IFN-γ and TNF-α from CXCR5-CD8+T cells increased in response to TCR stimulation. Interestingly, PD-1 expression was constantly retained on CXCR5+CD8+T cells while significantly decreased on CXCR5-CD8+T cells after successful antiretroviral treatment in chronic HIV-infected patients. Conclusions: PD-1+CXCR5+CD8+T cells are functional cytotoxic T cells during chronic HIV infection. PD-1+CXCR5+CD8+T cells may represent a novel therapeutic strategy for the disease.
36
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Se Jin Im, Masao Hashimoto, Michael Y. Gerner et al. · Nature · 2016 · 2.1K citations · Full text
Persephone Borrow, Hanna Lewicki, Beatrice H. Hahn et al. · Journal of Virology · 1994 · 1.9K citations · Full text